‘Under-the-radar’ companies could become hot acquisition targets in 2018
Nearly a dozen companies were identified in a report as potentially attractive for buyouts by larger firms. Japanese companies could be big players.
Inside Takeda’s R&D transformation
Deals and acquisitions, filling in pipeline gaps, externalizing assets that are no longer a good fit. What really goes on when pharma companies restructure their R&D approach?
presented by
Your Guide to the Best Vein Clinics in Orlando
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.
Top healthcare executives name the CEO they’d trade places with if given the chance
At the J.P. Morgan Healthcare Conference this week some of the biggest names in healthcare gathered to discuss the state of the biopharmaceuticals sector. Amidst all of the commotion, some executives took a moment to tell CNBC‘s Meg Tirrell which CEO (in any industry) they’d most like to trade places with if given the chance. […]